What is he best known for?
The fields of study he is best known for:
Bernard F. Erlanger spends much of his time researching Molecular biology, Biochemistry, DNA, Antibody and Stereochemistry.
His Molecular biology research incorporates elements of Metaphase, Chromosome, Satellite DNA, Genetics and Constitutive heterochromatin.
His DNA research is multidisciplinary, incorporating elements of DNA methylation, RNA, Nucleic acid thermodynamics, Nucleotide and 28S ribosomal RNA.
Bernard F. Erlanger has researched Antibody in several fields, including Blood proteins, Nucleic acid and Antigen.
His Antigen study combines topics from a wide range of disciplines, such as Purine metabolism and Serum albumin.
His research in Stereochemistry intersects with topics in Biophysics, Membrane potential, Fullerene and Electrophorus.
His most cited work include:
- The preparation and properties of two new chromogenic substrates of trypsin. (2773 citations)
- Steroid-protein conjugates. I. Preparation and characterization of conjugates of bovine serum albumin with testosterone and with cortisone. (723 citations)
- Protein-free culture medium (505 citations)
What are the main themes of his work throughout his whole career to date?
Bernard F. Erlanger mainly focuses on Molecular biology, Biochemistry, Antibody, DNA and Antigen.
The concepts of his Molecular biology study are interwoven with issues in Metaphase, Chromosome, Genetics, Methylation and Constitutive heterochromatin.
His study looks at the intersection of Biochemistry and topics like Hapten with Bovine serum albumin.
His Antibody study is concerned with Immunology in general.
His DNA study combines topics from a wide range of disciplines, such as RNA, Escherichia coli, Denaturation and Pyrimidine.
The Antigen study combines topics in areas such as Serum albumin and Globulin.
He most often published in these fields:
- Molecular biology (35.35%)
- Biochemistry (31.31%)
- Antibody (29.80%)
What were the highlights of his more recent work (between 1991-2007)?
- Molecular biology (35.35%)
- Monoclonal antibody (11.62%)
- Antibody (29.80%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Molecular biology, Monoclonal antibody, Antibody, Antigen and Biochemistry.
In his work, Bernard F. Erlanger performs multidisciplinary research in Molecular biology and Conjugate.
His study in the fields of Monoclonal under the domain of Monoclonal antibody overlaps with other disciplines such as Screening method.
His work carried out in the field of Antigen brings together such families of science as Adjuvant, Dextran, Vaccination, Immunogen and Serum albumin.
His studies in Serum albumin integrate themes in fields like Bovine serum albumin and Polyclonal antibodies.
His work on Peptide sequence, DNA and Interleukin 2 as part of general Biochemistry study is frequently linked to Isomerase activity, therefore connecting diverse disciplines of science.
Between 1991 and 2007, his most popular works were:
- Cellular localisation of a water-soluble fullerene derivative (394 citations)
- A Biologically Effective Fullerene (C60) Derivative With Superoxide Dismutase Mimetic Properties (231 citations)
- Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium. (152 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Biochemistry, Cyclosporin a, Lymphocyte, Antigen and Monoclonal antibody.
His work on Biochemistry deals in particular with Superoxide dismutase, Coenzyme Q – cytochrome c reductase, Antioxidant, Reactive oxygen species and Cytochrome c.
His Lymphocyte research integrates issues from Receptor, Cell culture, Mode of action and Lymphokine.
His research in Antigen intersects with topics in Radioimmunoassay, Antibody and Serum albumin.
His Antibody study is mostly concerned with Monoclonal and Epitope mapping.
His studies deal with areas such as Group-specific antigen, Virology, Molecular biology and Polyclonal antibodies as well as Monoclonal antibody.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
